No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study.
about
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainConcordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targetsJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Clinical baseline factors predict response to natalizumab: their usefulness in patient selectionJC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.A review on JC virus infection in kidney transplant recipients.Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study.Progressive multifocal leukoencephalopathy and natalizumab.Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab.
P2860
Q24619923-4ECA8338-8FF9-4C08-B997-1A1D9BFD168CQ26830569-39C5B320-5FA8-40D6-93F4-766F2D07DD1BQ26852060-950CE8B1-D3BD-41B4-A2E4-E1602C7D608FQ33712682-8F43F7E6-9300-4497-955E-06C85F5CA937Q36572168-F2266411-C49D-4574-9F3F-465E28AD1365Q36602840-14A5825F-ECC3-4C38-8C68-D1D4ECE6C768Q36885632-3E8DAA6D-5B12-4E96-959F-747524C2FBA9Q37885823-67236C88-CD99-4393-876D-4CB23CC2400EQ39039495-94E98A42-1674-4999-AD3E-80A311545D09Q40666987-DF23A907-D4D0-4FEF-A9C7-9177966184E2Q42204510-B877C52F-4F6C-4B70-BDF8-9AB917C543DDQ42274057-59DD02C6-D000-4887-B5BA-98B2448554B5
P2860
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@en
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@nl
type
label
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@en
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@nl
prefLabel
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@en
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@nl
P2093
P356
P1476
No evidence of JC virus reacti ...... : an 18 month follow-up study.
@en
P2093
Dario Seppi
Francesca Rinaldi
Giorgio Palú
Irene Mattisi
Luciano Rinaldi
Mariella Sanzari
Massimiliano Calabrese
Paola Grossi
Paola Perini
Paolo Gallo
P304
P356
10.1136/JNNP.2009.201079
P407
P577
2010-06-14T00:00:00Z